Denis, Hélèna L.
Alpaugh, Melanie
Alvarez, Claudia P.
Fenyi, Alexis
Barker, Roger A.
Chouinard, Sylvain
Arrowsmith, Cheryl H.
Melki, Ronald
Labib, Richard
Harding, Rachel J.
Cicchetti, Francesca http://orcid.org/0000-0001-5490-1961
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-168865)
Fonds de Recherche du Québec - Santé (28941)
Huntington Society of Canada
NIHR BioResource
Huntington's Disease Society of America
Article History
Received: 20 May 2022
Revised: 14 December 2022
Accepted: 23 December 2022
First Online: 18 January 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: HD patients and age-/gender-matched healthy controls were recruited from HD clinics in Quebec City, Montreal and Cambridge. Each site received approval from the relevant ethical committee (CHU de Québec, #A13-2-1096; CHU of Montreal, #2015-5705; Cambridge Central Regional Motor Ethics Committee, REC #03/303 & #08/H0306/26; Cambridge University Hospitals Foundation Trust Research and Development department, R&D #A085170 & #A091246).
: All participants provided informed written consent.
: Not applicable.